Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies

por Gurion, Ronit, Rozovski, Uri, Itchaki, Gilad, Gafter-Gvili, Anat, Leibovitch, Chiya, Raanani, Pia, Ben-Zvi, Haim, Szwarcwort, Moran, Taylor-Abigadol, Mor, Dann, Eldad J., Horesh, Nurit, Inbar, Tsofia, Tzoran, Inna, Lavi, Noa, Fineman, Riva, Ringelstein-Harlev, Shimrit, Horowitz, Netanel A.
Publicado 2021